Literature DB >> 11710702

The role of tissue factor in the antiphospholipid syndrome.

P M Dobado-Berrios1, C López-Pedrera, F Velasco, M J Cuadrado.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11710702     DOI： 10.1002/1529-0131(200111)44:11<2467::aid-art426>3.0.co;2-u

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  11 in total

Review 1.  Intravenous immunoglobulin therapy in antiphospholipid syndrome.

Authors:  Emiliana Konova
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

2.  Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies.

Authors:  Wolfgang Miesbach; Inge Scharrer; Ronald Asherson
Journal:  Clin Rheumatol       Date:  2006-01-25       Impact factor: 2.980

Review 3.  Potential use of statins in the treatment of antiphospholipid syndrome.

Authors:  Chary Lopez-Pedrera; Patricia Ruiz-Limon; M Angeles Aguirre; Antonio Rodriguez-Ariza; Maria José Cuadrado
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

4.  Accelerated rejection, thrombosis, and graft failure with angiotensin II type 1 receptor antibodies.

Authors:  Meghan H Pearl; Richard K Leuchter; Elaine F Reed; Qiuheng Zhang; Robert B Ettenger; Eileen W Tsai
Journal:  Pediatr Nephrol       Date:  2015-05-09       Impact factor: 3.714

Review 5.  Annexin A2: biology and relevance to the antiphospholipid syndrome.

Authors:  E Cockrell; R G Espinola; K R McCrae
Journal:  Lupus       Date:  2008-10       Impact factor: 2.911

6.  Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome.

Authors:  Gabriela Cesarman-Maus; Nina P Ríos-Luna; Arunkumar B Deora; Bihui Huang; Rosario Villa; Maria del Carmen Cravioto; Donato Alarcón-Segovia; Jorge Sánchez-Guerrero; Katherine A Hajjar
Journal:  Blood       Date:  2006-02-21       Impact factor: 22.113

Review 7.  Treatment and monitoring of patients with antiphospholipid antibodies and thrombotic history (Hughes syndrome).

Authors:  Maria J Cuadrado
Journal:  Curr Rheumatol Rep       Date:  2002-10       Impact factor: 4.592

8.  The role of angiotensin II type 1 receptor-activating antibodies in renal allograft vascular rejection.

Authors:  Duska Dragun
Journal:  Pediatr Nephrol       Date:  2007-03-06       Impact factor: 3.714

Review 9.  Cardiovascular risk in systemic autoimmune diseases: epigenetic mechanisms of immune regulatory functions.

Authors:  Chary López-Pedrera; Carlos Pérez-Sánchez; Manuel Ramos-Casals; Monica Santos-Gonzalez; Antonio Rodriguez-Ariza; Ma José Cuadrado
Journal:  Clin Dev Immunol       Date:  2011-09-14

10.  'Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients'.

Authors:  C Pérez-Sánchez; M A Aguirre; P Ruiz-Limón; N Barbarroja; Y Jiménez-Gómez; I Arias de la Rosa; A Rodriguez-Ariza; E Collantes-Estévez; P Segui; F Velasco; M J Cuadrado; R Teruel; R González-Conejero; C Martínez; Ch López-Pedrera
Journal:  Sci Rep       Date:  2016-08-09       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.